Imlygic,which bursts melanoma cells open and triggers immune response, can shrink localised tumours but is not proven to extend life, or says FDAThe US Food and Drug Administration has approved a first-of-a-kind drug that uses the herpes virus to infiltrate deadly skin cancer tumours,reducing their size in some cases. Related: The Guardian view on meat and cancer: a tiny of what you fancy will do you no harm | Editorial Continue reading...
Source: theguardian.com